Loading
Latest filing published 22 Sept 2026 for Hikma Pharmaceuticals PLC, €31k. Read the official filing
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Susan Ringdal appears in our data through filings on Hikma Pharmaceuticals PLC shares, published by RNS (LSE). Between 10 August 2023 and 21 September 2026, the trades on record add up to 17 filings.
Every open-market trade on record is a sale: 2 sales worth €713k. Other entries cover 15 share grants.
The newest entry dates from 22 September 2026: a share grant of €31k, in Hikma Pharmaceuticals PLC. Typically, a trade is published a median of 1 day after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations